Recombinant DLL3 (Rovalpituzumab Biosimilar) 抗体
This anti-DLL3 (Rovalpituzumab Biosimilar) antibody is a Humanized 单克隆 antibody detecting DLL3 (Rovalpituzumab Biosimilar) in FACS. Suitable for 人.
Quick Overview for Recombinant DLL3 (Rovalpituzumab Biosimilar) 抗体 (ABIN7093083)
抗原
DLL3 (Rovalpituzumab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Humanized
克隆类型
单克隆
标记
This DLL3 (Rovalpituzumab Biosimilar) antibody is un-conjugated
应用范围
Flow Cytometry (FACS)
质量等级
Research Grade
-
-
原理
- Anti-DLL3 (Rovalpituzumab biosimilar) mAb
-
产品特性
- SC0001-SCX,SC0002,sc0001-SCX
-
纯化方法
- Purified from cell culture supernatant by affinity chromatography
-
亚型
- IgG1
-
-
-
-
应用备注
- Flow Cyt 1:100
-
说明
-
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Reconstitute with deionized water
-
缓冲液
- Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
-
储存条件
- -20 °C,-80 °C
-
储存方法
- Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
-
有效期
- 12 months
-
-
- DLL3 (Rovalpituzumab Biosimilar)
-
物质类
- Biosimilar
-
背景
- Synonyms: SCDO1
-
UniProt
- Q9NYJ7
抗原
-
You are here:
